{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:08Z","timestamp":1781530328484,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2023LC2302"],"award-info":[{"award-number":["2023LC2302"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.prp.2025.155814","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T19:13:33Z","timestamp":1736190813000},"page":"155814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Renal cell carcinoma with ALK-TPM3 gene fusion and ALK amplification: A case report and literature review"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8016-8868","authenticated-orcid":false,"given":"Xinzhuo","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3790-3954","authenticated-orcid":false,"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155814_bib1","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.onc.1201062","article-title":"ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)","volume":"14","author":"Morris","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.155814_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Sci. (N.Y., N.Y.)"},{"key":"10.1016\/j.prp.2025.155814_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2353\/ajpath.2009.080755","article-title":"EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues","volume":"174","author":"Martelli","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0002-9440(10)65042-0","article-title":"Expression of the ALK tyrosine kinase gene in neuroblastoma","volume":"156","author":"Lamant","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib7","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1182\/blood-2003-04-1050","article-title":"ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma","volume":"102","author":"De Paepe","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.prp.2025.155814_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00109-007-0159-4","article-title":"Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma","volume":"85","author":"Du","year":"2007","journal-title":"J. Mol. Med. (Berl., Ger.)"},{"key":"10.1016\/j.prp.2025.155814_bib9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1541-7786.MCR-08-0522","article-title":"Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers","volume":"7","author":"Lin","year":"2009","journal-title":"Mol. Cancer Res.: MCR"},{"key":"10.1016\/j.prp.2025.155814_bib10","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1158\/0008-5472.CAN-10-4041","article-title":"Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene","volume":"71","author":"Murugan","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.155814_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/jhg.2012.87","article-title":"Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma","volume":"57","author":"Coco","year":"2012","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.prp.2025.155814_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4132\/KoreanJPathol.2013.47.5.452","article-title":"ALK-positive renal cell carcinoma in a large series of consecutively resected korean renal cell carcinoma patients","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib13","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc."},{"key":"10.1016\/j.prp.2025.155814_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.155814_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00428-013-1520-3","article-title":"Increased ALK1 copy number and renal cell carcinoma-a case report","volume":"464","author":"Ryan","year":"2014","journal-title":"Virchows Arch.: Int. J. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.leu.2403797","article-title":"What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?","volume":"19","author":"Turner","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2025.155814_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/2159-8290.CD-12-0009","article-title":"ALKoma: a cancer subtype with a shared target","volume":"2","author":"Mano","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2025.155814_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/187152007784111340","article-title":"Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy","volume":"7","author":"Gunby","year":"2007","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.prp.2025.155814_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology","volume":"13","author":"Hallberg","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.155814_bib23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc."},{"key":"10.1016\/j.prp.2025.155814_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.155814_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.23007","article-title":"Translocation carcinomas of the kidney","volume":"61","author":"Argani","year":"2022","journal-title":"Genes, Chromosomes Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?","volume":"38","author":"Smith","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/gcc.22346","article-title":"ALK-rearranged renal cell carcinomas in children","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes, Chromosomes Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib29","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.21037\/tau-20-1343","article-title":"Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review","volume":"9","author":"Zhou","year":"2020","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.prp.2025.155814_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00185","article-title":"ALK fusions in renal cell carcinoma: response to entrectinib","volume":"2","author":"Tao","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.prp.2025.155814_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073995","article-title":"Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review","volume":"23","author":"Iannantuono","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155814_bib32","article-title":"ALK inhibition with alectinib for refractory metastatic renal cell carcinoma with ALK rearrangement: a rare case report and literature review","volume":"8","author":"Kathuria-Prakash","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.prp.2025.155814_bib33","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.ejca.2010.04.006","article-title":"The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene","volume":"46","author":"Kelleher","year":"2010","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"key":"10.1016\/j.prp.2025.155814_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tig.2006.06.007","article-title":"Gene amplification in cancer","volume":"22","author":"Albertson","year":"2006","journal-title":"Trends Genet.: TIG"},{"key":"10.1016\/j.prp.2025.155814_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JTO.0b013e3181fb7cd6","article-title":"Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer","volume":"6","author":"Salido","year":"2011","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib36","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/bjc.2013.641","article-title":"ALK gene amplification is associated with poor prognosis in colorectal carcinoma","volume":"109","author":"Bavi","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.155814_bib37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2011.37.8588","article-title":"Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications","volume":"30","author":"van Gaal","year":"2012","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.155814_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144927","article-title":"Unproductive effects of ALK gene amplification and copy number gain in non-small-cell lung cancer. ALK Gene Amplification and copy gain in NSCLC","volume":"21","author":"Zito Marino","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155814_bib39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.leukres.2012.06.005","article-title":"Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"36","author":"Yu","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.prp.2025.155814_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jclinpath-2013-201655","article-title":"Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study","volume":"67","author":"Lee","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2025.155814_bib41","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ejca.2013.02.005","article-title":"Amplification but not translocation of anaplastic lymphoma kinase is a frequent event in oesophageal cancer","volume":"49","author":"Schoppmann","year":"2013","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"key":"10.1016\/j.prp.2025.155814_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3748\/wjg.v20.i1.183","article-title":"ALK gene copy number gain and its clinical significance in hepatocellular carcinoma","volume":"20","author":"Jia","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2025.155814_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20081834","article-title":"High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours","volume":"416","author":"Car\u00e9n","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.prp.2025.155814_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1593\/neo.11222","article-title":"Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer","volume":"13","author":"Wang","year":"2011","journal-title":"Neoplasia (N. Y., N. Y.)"},{"key":"10.1016\/j.prp.2025.155814_bib45","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1158\/0008-5472.CAN-11-3931","article-title":"Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer","volume":"72","author":"Ren","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.155814_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2011.11.013","article-title":"Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors","volume":"317","author":"Bagci","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2025.155814_bib47","article-title":"Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication","volume":"10","author":"Kim","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2025.155814_bib48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.lungcan.2013.01.019","article-title":"ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer","volume":"80","author":"Preusser","year":"2013","journal-title":"Lung Cancer (Amst., Neth.)"},{"key":"10.1016\/j.prp.2025.155814_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2559.2012.04356.x","article-title":"Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases","volume":"62","author":"Kim","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.155814_bib50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/2193-1801-2-497","article-title":"Presence of anaplastic lymphoma kinase in inflammatory breast cancer","volume":"2","author":"Robertson","year":"2013","journal-title":"SpringerPlus"},{"key":"10.1016\/j.prp.2025.155814_bib51","doi-asserted-by":"crossref","first-page":"108ra114","DOI":"10.1126\/scitranslmed.3002950","article-title":"Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma","volume":"3","author":"Bresler","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.prp.2025.155814_bib52","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.10556","article-title":"ALK amplification and crizotinib sensitivity in non-small cell lung cancer cell lines and patients report","author":"Khadija","year":"2012","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:38:47Z","timestamp":1777559927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":52,"alternative-id":["S0344033825000068"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155814","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal cell carcinoma with ALK-TPM3 gene fusion and ALK amplification: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155814"}}